AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 15, 2026, 15:57Early Bird Registration Opens for RCOG Female Reproductive Physiology Course – RCOG
-
Jul 15, 2026, 15:53ACOG Joins Coalition to Advance National Women’s Health Strategy – ACOG
-
Jul 15, 2026, 15:44From the Shadow of Pregnancy Loss to a New Pregnancy – RBMO
-
Jul 15, 2026, 15:27Supporting the Launch of the National Strategy to Close the Women’s Health Gap – ASRM
-
Jul 15, 2026, 15:21Sergio Haimovich: AI Is Already Reshaping Scientific Publishing and Disclosure Is Lagging Behind
-
Jul 15, 2026, 15:12The Egg’s Engine Is Fed Plenty of Fuel, It Just Can’t Burn It – Fertility Plus
-
Jul 15, 2026, 15:07Join the Ultrasound in Obstetrics and Gynecology Team as the UOG Social Media Editor – ISUOG
-
Jul 15, 2026, 14:56Can Ultrasound Reliably Detect Residual Cervical Cancer After Conization? – IJGC
-
Jul 15, 2026, 14:27Marco Zaccaria: A Great Webinar, Hosted By BSGE and BMUS